Literature DB >> 26944200

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons.

Elizabeth C Carroll1, Lei Jin2, Andres Mori1, Natalia Muñoz-Wolf1, Ewa Oleszycka1, Hannah B T Moran1, Samira Mansouri2, Craig P McEntee1, Eimear Lambe1, Else Marie Agger3, Peter Andersen3, Colm Cunningham4, Paul Hertzog5, Katherine A Fitzgerald6, Andrew G Bowie7, Ed C Lavelle8.   

Abstract

The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent cell-mediated immunity, but the mechanism by which it acts is not clear. We show that chitosan promotes dendritic cell maturation by inducing type I interferons (IFNs) and enhances antigen-specific T helper 1 (Th1) responses in a type I IFN receptor-dependent manner. The induction of type I IFNs, IFN-stimulated genes and dendritic cell maturation by chitosan required the cytoplasmic DNA sensor cGAS and STING, implicating this pathway in dendritic cell activation. Additionally, this process was dependent on mitochondrial reactive oxygen species and the presence of cytoplasmic DNA. Chitosan-mediated enhancement of antigen specific Th1 and immunoglobulin G2c responses following vaccination was dependent on both cGAS and STING. These findings demonstrate that a cationic polymer can engage the STING-cGAS pathway to trigger innate and adaptive immune responses.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944200      PMCID: PMC4852885          DOI: 10.1016/j.immuni.2016.02.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

Review 1.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Mitochondrial permeability transition triggers the release of mtDNA fragments.

Authors:  M Patrushev; V Kasymov; V Patrusheva; T Ushakova; V Gogvadze; A Gaziev
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

Review 4.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  A 2020 vision for vaccines against HIV, tuberculosis and malaria.

Authors:  Rino Rappuoli; Alan Aderem
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

6.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

7.  Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

Authors:  Cristina L Swanson; Timothy J Wilson; Pamela Strauch; Marco Colonna; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

Review 8.  Vaccine adjuvants: putting innate immunity to work.

Authors:  Robert L Coffman; Alan Sher; Robert A Seder
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

Review 9.  Designing vaccines based on biology of human dendritic cell subsets.

Authors:  Karolina Palucka; Jacques Banchereau; Ira Mellman
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Spectrum and mechanisms of inflammasome activation by chitosan.

Authors:  Chelsea L Bueter; Chrono K Lee; Jennifer P Wang; Gary R Ostroff; Charles A Specht; Stuart M Levitz
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

View more
  124 in total

1.  Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

Authors:  Andreja Erman; Veronika Križan Hergouth; Matthew G Blango; Mojca Kerec Kos; Matthew A Mulvey; Peter Veranic
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

2.  The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele.

Authors:  Seema Patel; Steven M Blaauboer; Heidi R Tucker; Samira Mansouri; Juan Sebastian Ruiz-Moreno; Lutz Hamann; Ralf R Schumann; Bastian Opitz; Lei Jin
Journal:  J Immunol       Date:  2016-12-07       Impact factor: 5.422

3.  The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.

Authors:  Alice Gutjahr; Laura Papagno; Francesco Nicoli; Tomohiro Kanuma; Nozomi Kuse; Mariela Pires Cabral-Piccin; Nicolas Rochereau; Emma Gostick; Thierry Lioux; Eric Perouzel; David A Price; Masafumi Takiguchi; Bernard Verrier; Takuya Yamamoto; Stéphane Paul; Victor Appay
Journal:  JCI Insight       Date:  2019-04-04

4.  Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.

Authors:  Tara L Martin; Junbae Jee; Eunsoo Kim; Haley E Steiner; Estelle Cormet-Boyaka; Prosper N Boyaka
Journal:  Vaccine       Date:  2017-03-24       Impact factor: 3.641

5.  Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance.

Authors:  Wu-Chang Zhang; Lin-Juan Du; Xiao-Jun Zheng; Xiao-Qing Chen; Chaoji Shi; Bo-Yan Chen; Xue-Nan Sun; Chao Li; Yu-Yao Zhang; Yan Liu; Hui Xiao; Qibin Leng; Xinquan Jiang; Zhiyuan Zhang; Shuyang Sun; Sheng-Zhong Duan
Journal:  J Biol Chem       Date:  2017-12-04       Impact factor: 5.157

Review 6.  The Emerging Roles of STING in Bacterial Infections.

Authors:  Fabio V Marinho; Sulayman Benmerzoug; Sergio C Oliveira; Bernhard Ryffel; V F J Quesniaux
Journal:  Trends Microbiol       Date:  2017-06-15       Impact factor: 17.079

7.  Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.

Authors:  Peter Hart; Alastair Copland; Gil Reynolds Diogo; Shane Harris; Ralf Spallek; Wulf Oehlmann; Mahavir Singh; Juan Basile; Martin Rottenberg; Matthew John Paul; Rajko Reljic
Journal:  Mol Ther       Date:  2017-12-22       Impact factor: 11.454

8.  Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.

Authors:  Nikhil Chauhan; Priyankana Banerjee; Vishal K Khatri; Andrew Canciamille; Jessica Gilles; Ramaswamy Kalyanasundaram
Journal:  Parasitol Res       Date:  2017-08-21       Impact factor: 2.289

9.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

10.  MHC class I and II peptide homology regulates the cellular immune response.

Authors:  Matthew M Halpert; Vanaja Konduri; Dan Liang; Jonathan Vazquez-Perez; Colby J Hofferek; Scott A Weldon; Yunyu Baig; Indira Vedula; Jonathan M Levitt; William K Decker
Journal:  FASEB J       Date:  2020-04-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.